The second bellwether case in the AndroGel multidistrict litigation came to an end when an Illinois federal jury ordered AbbVie Inc. to pay $140 million to Jeffrey Konrad, an AndroGel user, who suffered a heart attack two months after his doctor prescribed the testosterone replacement drug. […]
Oct 5, 2017
By Jessica Hoerman
AndroGel
